Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study
阿扎胞苷联合纳武利尤单抗治疗复发/难治性急性髓系白血病的疗效、安全性及反应生物标志物：一项非随机、开放标签的II期研究
期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-18-0774
Daver, Naval; Garcia-Manero, Guillermo; Basu, Sreyashi; Boddu, Prajwal C; Alfayez, Mansour; Cortes, Jorge E; Konopleva, Marina; Ravandi-Kashani, Farhad; Jabbour, Elias; Kadia, Tapan; Nogueras-Gonzalez, Graciela M; Ning, Jing; Pemmaraju, Naveen; DiNardo, Courtney D; Andreeff, Michael; Pierce, Sherry A; Gordon, Tauna; Kornblau, Steven M; Flores, Wilmer; Alhamal, Zainab; Bueso-Ramos, Carlos; Jorgensen, Jeffrey L; Patel, Keyur P; Blando, Jorge; Allison, James P; Sharma, Padmanee; Kantarjian, Hagop
